Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burt Nabors

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
International Journal of Surgical Pathology|July 17, 2016
Primary Sellar Rhabdomyosarcoma Arising in Association With a Pituitary AdenomaVirginia E Duncan, L Burt Nabors, Paula P Warren, et al.
Neuro-Oncology|February 13, 2009
Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastomaNichole L Bryant, Catalina Suarez-Cuervo, G Yancey Gillespie, et al.
Cancer Genetics|May 18, 2025
Glioma grade and mortality in relation to sequence variation in the mitochondrial genomeNoah C Peeri, Jamie K Teer, Zachary J Thompson, et al.
Neuro-Oncology Advances|October 17, 2022
Targeting the TREM1-positive myeloid microenvironment in glioblastomaNatalia Filippova, Jeffrey M Grimes, Jianmei W Leavenworth, et al.
Cancer Research|June 18, 2002
Human cytomegalovirus infection and expression in human malignant gliomaCharles S Cobbs, Lualhati Harkins, Minu Samanta, et al.
Mitochondrion|January 15, 2022
Mitochondrial DNA sequence variation and risk of gliomaClaudine M Samanic, Jamie K Teer, Zachary J Thompson, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2018
Associations of anticoagulant use with outcome in newly diagnosed glioblastomaEmilie Le Rhun, Els Genbrugge, Roger Stupp, et al.
Neuro-Oncology Advances|July 9, 2024
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastomaSamuel Ryu, Xiaobu Ye, Jeffrey J Olson, et al.
Journal of Neuro-Oncology|April 20, 2022
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictorsAndrew B DeAtkine, Moaaz Abdelrashid, Zach Tucker, et al.
Journal of Neuro-Oncology|March 10, 2010
Phase 1 clinical trial of bortezomib in adults with recurrent malignant gliomaSurasak Phuphanich, Jeffrey G Supko, Kathryn A Carson, et al.
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
International Journal of Surgical Pathology|July 17, 2016
Primary Sellar Rhabdomyosarcoma Arising in Association With a Pituitary AdenomaVirginia E Duncan, L Burt Nabors, Paula P Warren, et al.
Neuro-Oncology|February 13, 2009
Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastomaNichole L Bryant, Catalina Suarez-Cuervo, G Yancey Gillespie, et al.
Cancer Genetics|May 18, 2025
Glioma grade and mortality in relation to sequence variation in the mitochondrial genomeNoah C Peeri, Jamie K Teer, Zachary J Thompson, et al.
Neuro-Oncology Advances|October 17, 2022
Targeting the TREM1-positive myeloid microenvironment in glioblastomaNatalia Filippova, Jeffrey M Grimes, Jianmei W Leavenworth, et al.
Cancer Research|June 18, 2002
Human cytomegalovirus infection and expression in human malignant gliomaCharles S Cobbs, Lualhati Harkins, Minu Samanta, et al.
Mitochondrion|January 15, 2022
Mitochondrial DNA sequence variation and risk of gliomaClaudine M Samanic, Jamie K Teer, Zachary J Thompson, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2018
Associations of anticoagulant use with outcome in newly diagnosed glioblastomaEmilie Le Rhun, Els Genbrugge, Roger Stupp, et al.
Neuro-Oncology Advances|July 9, 2024
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastomaSamuel Ryu, Xiaobu Ye, Jeffrey J Olson, et al.
Journal of Neuro-Oncology|April 20, 2022
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictorsAndrew B DeAtkine, Moaaz Abdelrashid, Zach Tucker, et al.
Journal of Neuro-Oncology|March 10, 2010
Phase 1 clinical trial of bortezomib in adults with recurrent malignant gliomaSurasak Phuphanich, Jeffrey G Supko, Kathryn A Carson, et al.
Pageof 16